Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Micardis®; Drug: Micardis® Plus

Study type: Observational

Funder types: Industry

Identifiers

NCT02242357

502.427

Details and patient eligibility

About

Study to evaluate efficacy and tolerability of Micardis®/Micardis® Plus under usual daily-practice prescribing conditions in hypertensive patients

Enrollment: 14,553 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males and females for whom a medical antihypertensive therapy is indicated
• Age >= 18 years

Exclusion criteria

• Age < 18 years

Trial design

14,553 participants in 1 patient group

Patients with hypertension

Treatment:

Drug: Micardis® Plus

Drug: Micardis®